SCHEMBL6289300

SCHEMBL6289300

Fc1ccccc1Oc1ccccc1Oc1cccc(Oc2ccc(Oc3cccc(Oc4ccccc4Oc4ccccc4F)c3)cc2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP10 Q53GL7 1/20 0.51
ALDH1A1 P00352 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
MEN1 O00255 1/20 0.47
MITF O75030 1/20 0.47
GAA P10253 1/20 0.47
MAPT P10636 1/20 0.47
GFER P55789 1/20 0.47
KMT2A Q03164 1/20 0.47
NLRP1 Q9C000 1/20 0.47
NOD2 Q9HC29 1/20 0.47
FAAH O00519 1/20 0.45
MAPK1 P28482 1/20 0.44
HTT P42858 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
HTR1A P08908 5/20 0.44
SLC6A2 P23975 5/20 0.44
SLC6A3 Q01959 4/20 0.44
RHEB Q15382 1/20 0.42
SLC6A4 P31645 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6293774 1.00 PARP10 (0.51) PARP10ALDH1A1SMN1; SMN2MEN1MITF
SCHEMBL6290500 0.96 PARP10 (0.54) PARP10ALDH1A1SMN1; SMN2MEN1MITF
SCHEMBL6293813 0.92 PARP10 (0.49) PARP10ALDH1A1SMN1; SMN2MEN1MITF
SCHEMBL6289259 0.92 PARP10 (0.49) PARP10ALDH1A1SMN1; SMN2MEN1MITF
SCHEMBL6290439 0.92 PARP10 (0.49) PARP10ALDH1A1SMN1; SMN2MEN1MITF
SCHEMBL6290371 0.90 PARP10 (0.59) PARP10ALDH1A1MEN1KMT2AFAAH
SCHEMBL6290746 0.90 PARP10 (0.59) PARP10ALDH1A1MEN1KMT2AFAAH
SCHEMBL6290619 0.90 PARP10 (0.50) PARP10ALDH1A1MEN1GAAKMT2A
SCHEMBL6290343 0.88 PARP10 (0.61) PARP10ALDH1A1MEN1KMT2AFAAH
SCHEMBL6293904 0.88 PARP10 (0.61) PARP10ALDH1A1MEN1KMT2AFAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6933411-B2 Aromatic diamine and polyimide thereof MITSUI CHEMICALS, INC. (JP) 2005-08-23 US disclosed
US-6737503-B2 LOW TEMPERATURE ADHESIVE BONDING MITSUI CHEMICALS, INC. (JP) 2004-05-18 US disclosed
US-20040082754-A1 Novel aromatic diamine and polyimide thereof MITSUI CHEMICALS, INC. (JP) 2004-04-29 US disclosed
US-20030092870-A1 Novel aromatic diamine and polyimide thereof MITSUI CHEMICALS, INC. (JP) 2003-05-15 US disclosed
EP-1288191-A2 Novel aromatic diamine and polyimide thereof Mitsui Chemicals, Inc. (JP) 2003-03-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030092870-A1 Novel aromatic diamine and polyimide thereof DDT, AOC1, H1-4 PARP10 1693/4885ALDH1A1 902/4885SMN1; SMN2 2287/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.